CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-23 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −499 | $107.40 | $54K | 77,418 |
| 2024-07-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,250 | 78,976 | ||
| 2024-07-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,059 | $105.16 | $111K | 77,917 |
| 2024-07-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,250 | 6,250 | ||
| 2024-07-22 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −549 | $105.16 | $58K | 113,637 |
| 2024-07-22 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −549 | $105.16 | $58K | 109,391 |
| 2024-07-22 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,638 | $105.16 | $277K | 210,377 |
| 2024-07-22 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −815 | $105.16 | $86K | 207,457 |
| 2024-07-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,145 | 77,726 | ||
| 2024-07-21 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,145 | 2,290 | ||
| 2024-07-21 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +1,774 | 213,015 | ||
| 2024-07-21 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,774 | 3,550 | ||
| 2024-07-21 | Sheena Jonathan Director | Exercise or conversion | +143 | 302,141 | ||
| 2024-07-21 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit | −143 | 287 | ||
| 2024-07-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +644 | 208,272 | ||
| 2024-07-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −644 | 1,288 | ||
| 2024-07-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,522 | 76,581 | ||
| 2024-07-20 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,522 | 9,131 | ||
| 2024-07-20 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +3,386 | 211,241 | ||
| 2024-07-20 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion · Restricted Stock Unit 10b5-1 | −3,386 | 20,316 |
Page 69 of 85 · 1,682 trades